CTXR
Citius Pharmaceuticals Inc
Price:  
1.29 
USD
Volume:  
310,758.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTXR Relative Valuation

-4324.8%
Upside

As of 2025-08-04, the Relative Valuation of Citius Pharmaceuticals Inc (CTXR) is (54.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Citius Pharmaceuticals Inc based on Relative Valuation is -4324.8%.

The range of the Relative Valuation is (52.09) - (53.25) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.8x - 18.3x 17.4x
Forward P/E multiples 17.9x - 22.8x 20.2x
Fair Price (52.09) - (53.25) (54.50)
Upside -4137.8% - -4227.9% -4324.8%
1.29 USD
Stock Price
(54.50) USD
Fair Price

CTXR Relative Valuation - Historical P/E Data

Date P/E
2025-08-01 -0.44
2025-07-31 -0.47
2025-07-30 -0.48
2025-07-29 -0.51
2025-07-28 -0.53
2025-07-25 -0.57
2025-07-24 -0.58
2025-07-23 -0.57
2025-07-22 -0.50
2025-07-21 -0.50
2025-07-18 -0.53
2025-07-17 -0.55
2025-07-16 -0.51
2025-07-15 -0.56
2025-07-14 -0.57
2025-07-11 -0.54
2025-07-10 -0.56
2025-07-09 -0.61
2025-07-08 -0.67
2025-07-07 -0.72
2025-07-03 -0.76
2025-07-02 -0.72
2025-07-01 -0.65
2025-06-30 -0.55
2025-06-27 -0.53
2025-06-26 -0.46
2025-06-25 -0.41
2025-06-24 -0.44
2025-06-23 -0.35
2025-06-20 -0.37
2025-06-18 -0.31
2025-06-17 -0.29
2025-06-16 -0.27
2025-06-13 -0.30
2025-06-12 -0.32
2025-06-11 -0.35
2025-06-10 -0.36
2025-06-09 -0.47
2025-06-06 -0.29
2025-06-05 -0.29
2025-06-04 -0.30
2025-06-03 -0.30
2025-06-02 -0.26
2025-05-30 -0.23
2025-05-29 -0.24
2025-05-28 -0.24
2025-05-27 -0.24
2025-05-23 -0.24
2025-05-22 -0.25
2025-05-21 -0.23